Dr. Petar Bajic

Dr. Petar Bajic
Dr. Petar Bajic is the Center Director for Men's Health at the Glickman Urological and Kidney Institute in Cleveland, Ohio. A board-certified urologist with fellowship training in men's sexual and urinary dysfunction, he also serves as an Assistant Professor of Urology at the Cleveland Clinic Lerner College of Medicine. Dr. Bajic received his medical degree from the University of Toledo College of Medicine, and completed his urology residency training at Loyola University Medical Center in Chicago, Illinois. He then went on to complete a fellowship in Andrology and Male Genital Reconstructive Surgery at Rush University Medical Center in Chicago. Dr. Bajic is the chair of the Young Clinicians Committee of the Sexual Medicine Society of North America and holds committee appointments in several national and international professional organizations. He is an avid researcher in the areas of sexual and urinary dysfunction, and is involved in patient advocacy efforts on the national and state levels. As Director of the Center for Men's Health, Dr. Bajic oversees the center's operations, including clinical care, research, and education. He is committed to advancing the field of men's health and improving access to cutting edge men's health care. Dr. Bajic specializes in treating men for erectile dysfunction, Peyronie’s disease (penile curvature), sexual and urinary dysfunction due to cancer treatment, low testosterone, vasectomy, and prostate issues.
Medical School:

University of Toledo College of Medicine

Residency:

Loyola University Chicago

Fellowship:

Rush University Chicago

Locations

Cleveland Clinic Cleveland, Ohio

9500 Euclid AveCleveland, Ohio, 44195United States
216-444-1231 | Visit Website

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only